Paget's disease of bone
Paget’s disease of bone: an osteoimmunological disorder?
... between bone and immune ...Paget’s disease of bone is a common metabolic bone disorder, resulting from an excessively increased bone resorption coupled with aberrant bone ...
13
Current options for the treatment of Paget’s disease of the bone
... Paget’s disease of bone (PDB) is a chronic bone remodelling disorder characterized by increased osteoclast-mediated bone resorption, with subsequent compensatory increases in new bone ...
14
Current perspectives on bisphosphonate treatment in Paget’s disease of bone
... In spite of that, there were no significant differences identified in quality of life, overall bodily pain, or in pagetic bone pain between the groups. Similarly, hearing thresholds, as assessed by audiometry, did ...
7
Emerging strategies and therapies for treatment of Paget’s disease of bone
... Figure 2 Pathogenesis of Paget’s disease of bone: viral and genetic interactions, unifying hypothesis. Schematic models of cytoplasmic autophagy in A) normal hematopoietic progenitors with adequate ...
15
<p>Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget’s Disease Harboring Triple Uncommon HER2 Mutation: A Case Report</p>
... with bone-metastatic scrotal Paget ’ s disease harboring triple uncommon HER2 mutations ...scrotal Paget ’ s disease harbor- ing triple uncommon HER2 mutation who responds ...
5
Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant
... early-onset Paget disease and frontotemporal dementia (IBMPFD) ...opathy, Paget disease of bone, and frontotemporal demen- tia (FTD) ...Paget’s disease, and 30% for FTD ...
14
Clinical Reasoning: Progressive proximal weakness in a 56-year-old man with bone pain
... Rimmed vacuoles are a nonspecific finding in many myo- pathies, including sporadic IBM (sIBM) and myofibrillar myopathy (MFM). As noted previously, the patient’s pattern of muscle involvement was not typical for sIBM. There ...
7
Paget disease of bone
... the disease remains highly localized to a particular bone or bones rather than affecting the entire skeleton, and the fact that the incidence and severity of the disease has been chang- ing over the ...
10
← Return to Article Details A CASE STUDY ABOUT THE EFFECT OF ASTHISHRIKLA GHRIT MATRA VASTI IN THE MANAGEMENT OF ASTHIKSHAYA W.S.R.TO. OSTEOPOROSIS
... from bone, decreases renal calcium excretion, and increases renal production of 1,25- dihydroxyvitamin D (1,25[OH]2 D)-an active hormonal form of vitaminD that optimizes calcium and phosphorus absorption, inhibits ...
7
Original Article Expression of vascular endothelial growth factor and basic fibroblast growth factor in extramammary Paget disease
... Abstract: Extramammary Paget’s disease (EMPD) is a special type of cancers. The etiology of the disease is still unclear. We aimed to study the expression differences of vascular endothelial growth factor ...
7
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
... Interestingly, 6 weeks of systemic in vivo treatment with pravastatin did not influence CKD progression or renal fibrosis in our model of established CKD. Although cholesterol-lowering effects of statins do not occur in ...
13
Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease
... [54]. Bone metabolism in children is characterized by predominant bone modeling with simultaneous activity of both osteoblasts and osteoclasts on different parts of the ...of bone loss observed in ...
8
Mineral bone disorders (MBD) in patients on peritoneal dialysis
... may influence the grade of vascular calcification and osteoporosis. In addition, high-glucose PD solution may lead to low-turnover bone, and further studies are needed to explore whether it is true or not. ...
6
Sclerostin : a key regulator of bone metabolism
... between bone resorption and bone formation, in favor of resorption, is the predominant pathogenetic factor for bone loss while during the second, chronic, phase reduced bone formation and ...
188
Mandibular bone mineral density in patients with Behçet’s disease
... The study included 45 adults with BD (male/female: 24/21) and 30 volunteer healthy adults (male/female: 15/15) as a control group. All patients gave informed written con- sent. A questionnaire was used to collect ...
5
Lung function and associations with multiple dimensions of dental health: a prospective observational cross sectional study
... alveolar bone loss with regard to the presence of ...alveolar bone loss in COPD marginally failed statistical significance in univariate analysis, whereas in another study [12] it was very well associated ...
9
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
... When considering HSCT, the question remains whether its risk to benefit ratio justifies it. Observations of case re- ports published to date suggest that sustained clinical re- mission with HSCT is initially likely to ...
15
Cross Sectional study on Metabolic Bone disease in non cholestatic chronic liver disease.
... liver disease) represents a disorder which causes progressive hepatic fibrosis characterized by distorted liver architecture and the formation of nodules which are ...liver disease following treatment of ...
85
Radiographic features of osteogenesis imperfecta
... normal children who suffer trauma and usually consoli- date within the normally expected times. Some children may have few or no fractures, whereas others experience numerous fractures throughout their lives, especially ...
13
Bone resorption predicts for skeletal complications in metastatic bone disease
... responsive bone markers in metastatic bone disease and results from the present study are encouraging, it would be desirable to study the relationship between skeletal events and other urine and ...
7